This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
GeoVax advances GEO-MVA mpox vaccine toward Phase 3 trial under expedited EMA pathway, with planned enrollment of 500 participants. Also expanding immuno-oncology pipeline with Gedeptin combination strategies. #Biotech #Vaccines
2026-05-21T01:06:08.477Z